Anika Therapeutics Ownership | Who Owns Anika Therapeutics?


OverviewRevenueFinancialsChartTranscripts

Anika Therapeutics Ownership Summary


Anika Therapeutics is owned by 90.07% institutional investors, 3.42% insiders, and 6.51% retail investors. Trigran investments is the largest institutional shareholder, holding 14.53% of ANIK shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.97% of its assets in Anika Therapeutics shares.

ANIK Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockAnika Therapeutics90.07%3.42%6.51%
SectorHealthcare Stocks 46.98%7.90%45.12%
IndustryMedical Device Stocks50.53%7.92%41.55%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Trigran investments2.14M14.53%$54.11M
Blackrock1.61M10.93%$40.70M
Caligan partners lp1.44M9.77%$36.37M
Vanguard group790.14K5.38%$20.01M
Dimensional fund advisors lp749.28K5.10%$18.98M
Renaissance598.23K4.07%$15.15M
Morgan stanley501.99K3.42%$12.72M
Boothbay fund management501.95K3.42%$12.71M
Acadian asset management442.94K3.01%$11.22M
Geode capital management341.07K2.32%$8.64M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Caligan partners lp1.44M8.50%$36.37M
Trigran investments2.14M5.66%$54.11M
Stonepine capital management165.40K3.82%$4.19M
Meros investment management, lp212.71K2.55%$5.39M
Alta fundamental advisers296.08K2.38%$7.50M
Capital management corp /va328.62K1.67%$8.32M
Diker management56.24K1.21%$1.42M
Virtus investment advisers45.58K0.98%$1.15M
Ironwood investment management28.70K0.39%$727.07K
Boothbay fund management501.95K0.30%$12.71M

Top Buyers

HolderShares% AssetsChange
Segall bryant & hamill107.00K0.05%107.00K
Stonepine capital management165.40K3.82%104.45K
Globeflex capital l p98.00K0.26%65.86K
Trigran investments2.14M5.66%63.81K
Blackrock1.61M0.00%45.79K

Top Sellers

HolderShares% AssetsChange
Morgan stanley501.99K0.00%-199.74K
Nuveen asset management100.08K0.00%-96.10K
Millennium management30.71K0.00%-85.38K
Dimensional fund advisors lp749.28K0.01%-60.47K
Capital management corp /va328.62K1.67%-35.41K

New Positions

HolderShares% AssetsChangeValue
Segall bryant & hamill107.00K0.05%107.00K$2.71M
Verition fund management11.71K0.00%11.71K$296.61K
Voya investment management9.90K0.00%9.90K$250.84K
Mirae asset global etfs8.13K0.00%8.13K$206.06K
Corebridge financial7.88K0.00%7.88K$199.57K

Sold Out

HolderChange
Nelson, van denburg & campbell wealth management group-3.00
Covestor-24.00
Quarry lp-29.00
Simplex trading-104.00
Metropolitan life insurance co/ny-831.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 2024113-6.61%13,237,819-1.18%901.08%49-14.04%4714.63%
Mar 31, 20241213.42%13,396,4641.35%911.12%57-6.56%412.50%
Dec 31, 2023117-0.85%13,218,4421.65%901.14%617.02%40-11.11%
Sep 30, 20231180.85%13,003,870-0.51%881.12%571.79%4525.00%
Jun 30, 2023117-5.65%13,071,1360.23%881.12%565.66%36-23.40%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv439.41K2.97%-
iShares Russell 2000 ETF348.95K2.38%-784.00
Vanguard Institutional Extnd Mkt Idx Tr257.20K1.74%5.88K
CMC SMID196.52K1.33%-7.22K
Fidelity Small Cap Index147.57K1.00%-5.08K
Franklin Mutual Small-Mid Cap Val A120.97K0.82%-8.34K
DFA US Targeted Value I118.24K0.80%-3.76K
DFA US Micro Cap I112.33K0.76%-
iShares Russell 2000 Value ETF101.54K0.69%-
State St Russell Sm/Mid Cp® Indx NL Cl C94.66K0.65%-2.90K

Recent Insider Transactions


DateNameRoleActivityValue

Insider Transactions Trends


DateBuySell
2024 Q3--
2024 Q2--
2024 Q1--
2023 Q4--
2023 Q3--

ANIK Ownership FAQ


Who Owns Anika Therapeutics?

Anika Therapeutics shareholders are primarily institutional investors at 90.07%, followed by 3.42% insiders and 6.51% retail investors. The average institutional ownership in Anika Therapeutics's industry, Medical Device Stocks, is 50.53%, which Anika Therapeutics exceeds.

Who owns the most shares of Anika Therapeutics?

Anika Therapeutics’s largest shareholders are Trigran investments (2.14M shares, 14.53%), Blackrock (1.61M shares, 10.93%), and Caligan partners lp (1.44M shares, 9.77%). Together, they hold 35.24% of Anika Therapeutics’s total shares outstanding.

Does Blackrock own Anika Therapeutics?

Yes, BlackRock owns 10.93% of Anika Therapeutics, totaling 1.61M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 40.7M$. In the last quarter, BlackRock increased its holdings by 45.79K shares, a 2.93% change.

Who is Anika Therapeutics’s biggest shareholder by percentage of total assets invested?

Caligan partners lp is Anika Therapeutics’s biggest shareholder by percentage of total assets invested, with 8.50% of its assets in 1.44M Anika Therapeutics shares, valued at 36.37M$.

Who is the top mutual fund holder of Anika Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Anika Therapeutics shares, with 2.97% of its total shares outstanding invested in 439.41K Anika Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools